World’s most adopted healthcare AI
World’s most adopted healthcare AI
World’s most adopted healthcare AI
Transforming healthcare pathways with AI
1
Advancing public health access for Tuberculosis, Pediatric TB and beyond
WHO evaluated AI solutions to support clinicians in making quick and accurate diagnosis and treatment decisions. This provides global access to Tuberculosis, Silicosis, and Pediatric Tuberculosis care and real-time disease surveillance.
1
Advancing public health access for Tuberculosis, Pediatric TB and beyond
WHO evaluated AI solutions to support clinicians in making quick and accurate diagnosis and treatment decisions. This provides global access to Tuberculosis, Silicosis, and Pediatric Tuberculosis care and real-time disease surveillance.
1
Advancing public health access for Tuberculosis, Pediatric TB and beyond
WHO evaluated AI solutions to support clinicians in making quick and accurate diagnosis and treatment decisions. This provides global access to Tuberculosis, Silicosis, and Pediatric Tuberculosis care and real-time disease surveillance.
1
Accelerating early detection and management of lung cancer
The end-to-end lung cancer care continuum detects lung nodules early, measures for disease progression and manages cases to support clinicians, improving outcomes for patients. It also helps advance developments for lung health in the pharmaceutical industry.
1
Accelerating early detection and management of lung cancer
The end-to-end lung cancer care continuum detects lung nodules early, measures for disease progression and manages cases to support clinicians, improving outcomes for patients. It also helps advance developments for lung health in the pharmaceutical industry.
1
Accelerating early detection and management of lung cancer
The end-to-end lung cancer care continuum detects lung nodules early, measures for disease progression and manages cases to support clinicians, improving outcomes for patients. It also helps advance developments for lung health in the pharmaceutical industry.
Qure products
qXR
AI for reporting on chest X-rays
1
Comprehensive findings across lungs, pleura, mediastinum, bones, diaphragm, and heart
1
Comprehensive findings across lungs, pleura, mediastinum, bones, diaphragm, and heart
1
Comprehensive findings across lungs, pleura, mediastinum, bones, diaphragm, and heart
2
Blazing fast high-volume reporting for Telerads & Immigration screenings
2
Blazing fast high-volume reporting for Telerads & Immigration screenings
2
Blazing fast high-volume reporting for Telerads & Immigration screenings
3
Augment productivity with pre-filled reports and AI overlays
3
Augment productivity with pre-filled reports and AI overlays
3
Augment productivity with pre-filled reports and AI overlays
4
Catch Incidental findings for Lung cancer & Heart failure
4
Catch Incidental findings for Lung cancer & Heart failure
4
Catch Incidental findings for Lung cancer & Heart failure
5
Clear backlogs by segregating unremarkable CXRs
5
Clear backlogs by segregating unremarkable CXRs
5
Clear backlogs by segregating unremarkable CXRs
6
Active case finding for TB & Lung Cancer screening
6
Active case finding for TB & Lung Cancer screening
6
Active case finding for TB & Lung Cancer screening
qTrack app
AI powered TB care cascades
World’s most widely used AI for comprehensive chest X-ray reporting. Pre-read assistance in 20 seconds with findings across the lung, heart, pleura, mediastinum, bones & diaphragm.
360k+
Critical Notifications sent; 2.6 M CXRs processed
$200
Cost saved per notified case
50%
Cost savings on confirmatory tests
25%
Additional TB cases detected via Incidental pathway
99%
reduction in TAT to confirmed diagnosis; from 3 weeks to 2 hrs
55+
countries, 1900+ sites
AI assistant for trauma MSK X-rays
15
Anatomies with multiple views
<20 sec
Processing time; trained on 1 M+ scans
>0.9
Sensitivity to detect signs of fracture
qLC-Suite
AI for early lung cancer detection
World’s most widely used AI for comprehensive chest X-ray reporting. Pre-read assistance in 20 seconds with findings across lung, heart, pleura, mediastinum, bones & diaphragm
4.5M+
Chest X-Rays processed globally for Lung Cancer
9/10
Missed nodules identified by radiologists using qXR
1000+
Sites using qXR for early detection of Lung Cancer
46%
Faster reporting for nodules with qCT
40%
Fewer nodules missed with qXR
24%
Improvement in assigning malignancy risk using qCT
Neurocritical care suite
Comprehensive AI solutions for intracranial hemorrhage management and stroke care
8M+
Scans processed globally
97%
Sensitivity for Intracranial Hemorrhage (ICH) detection
<5 Minutes
To alert clinical teams with ai support
7% Boost
In ICH detection sensitivity for er physicians with AI support
6x Increase
In patients treated within 30 minutes of CT scans
30% Reduction
30% Reduction
Improvement in assigning malignancy risk using qCT
qXR-HF
Incidental detection of heart failure risk
4.4 M
Scans for Training
2%
Non-Cardiology X-rays flagged as High Risk
86%
Precision in flagging at-risk cases
Testimonials
AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.
David M. Rubin , Managing Director at Merck Global Health Innovation Fund LLC
Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.
Llang Bridget M. Maama-Maime, National TB Programme Manager at Ministry of Health, Lesotho
We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.
Dr. Seraphine Kaminsa, Senior Technical Tuberculosis Advisor at Save The Children US
Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.
Prof. David Lowe, Professor of Health Innovation at University of Glasgow
AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.
David M. Rubin , Managing Director at Merck Global Health Innovation Fund LLC
AI has the potential to power the early diagnosis of lung cancer, TB or Stroke giving the best chance of survival outcomes and improving quality of life for patients. Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations.
David M. Rubin , Managing Director at Merck Global Health Innovation Fund LLC
Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.
Llang Bridget M. Maama-Maime, National TB Programme Manager at Ministry of Health, Lesotho
Qure’s AI technology fits in all kinds of machines, new or old, making sure that we can use the old hardware and save our resources. By integrating Qure.ai with our existing X-ray systems, we can now screen patients promptly, obtain immediate results, and promptly refer clients for further investigation, ensuring timely management of TB cases.
Llang Bridget M. Maama-Maime, National TB Programme Manager at Ministry of Health, Lesotho
We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.
Dr. Seraphine Kaminsa, Senior Technical Tuberculosis Advisor at Save The Children US
We definitely need to have a quick movement on children. I think children are always left a bit behind. So, it's so exciting that Qure is really looking into and trying to find a way to include the children in the screening with modern digital platforms.
Dr. Seraphine Kaminsa, Senior Technical Tuberculosis Advisor at Save The Children US
Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.
Prof. David Lowe, Professor of Health Innovation at University of Glasgow
Lung cancer detection is a significant challenge for healthcare systems globally, with nearly 50% of patients diagnosed at stage 4, leading to poorer outcomes. By using Qure’s AI solution to enhance the speed and accuracy of chest X-rays performed annually at NHSGGC, we can expedite further imaging and treatment, improving patient care throughout the pathway.
Prof. David Lowe, Professor of Health Innovation at University of Glasgow
In media
In media
Presenters
Jai Bassi
Senior Director at Qure.ai
Fawwaz Chiwne
Senior Engineer at Qure.ai
In media
Presenters
Jai Bassi
Senior Director at Qure.ai
Fawwaz Chiwne
Senior Engineer at Qure.ai
Registered Office:
Level 7, Commerz II, International Business Park, Oberoi Garden City,Off. W. E.Highway, Goregaon (E), Mumbai City, Mumbai, Maharashtra, India, 400063
Phone: +91 22 6850 5800
Email: investorrelations@fractal.ai
CIN : U72400MH2000PLC125369
GST Number (Maharashtra) : 27AAACF4502D1Z8
Registered Office:
Level 7, Commerz II, International Business Park, Oberoi Garden City,Off. W. E.Highway, Goregaon (E), Mumbai City, Mumbai, Maharashtra, India, 400063
Phone: +91 22 6850 5800
Email: investorrelations@fractal.ai
CIN : U72400MH2000PLC125369
GST Number (Maharashtra) : 27AAACF4502D1Z8
Registered Office:
Level 7, Commerz II, International Business Park, Oberoi Garden City,Off. W. E.Highway, Goregaon (E), Mumbai City, Mumbai, Maharashtra, India, 400063
Phone: +91 22 6850 5800
Email: investorrelations@fractal.ai
CIN : U72400MH2000PLC125369
GST Number (Maharashtra) : 27AAACF4502D1Z8
Presenters
Jai Bassi
Senior Director at Qure.ai
Fawwaz Chiwne
Senior Engineer at Qure.ai
